BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/16/2024 7:57:40 AM | Browse: 220 | Download: 1132
Publication Name World Journal of Clinical Cases
Manuscript ID 88389
Country China
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Orthopedics
Manuscript Type Meta-Analysis
Article Title Systematic review and network meta-analysis of different non-steroidal anti-inflammatory drugs for juvenile idiopathic arthritis
Manuscript Source Unsolicited Manuscript
All Author List Tao Zeng, Jian-Zhong Ye, Hui Qin and Qian-Qian Xu
ORCID
Author(s) ORCID Number
Qian-Qian Xu http://orcid.org/0000-0002-3086-4104
Funding Agency and Grant Number
Funding Agency Grant Number
Science and Technology Plan Project of Jingmen Science and Technology Bureau 2018YFZD025
Corresponding Author Qian-Qian Xu, MD, Senior Statistician, College of Medicine, Jingchu University of Technology Jingmen, No. 33 Xiangshan Road, Jingmen 448000, Hubei Province, China. yanfenjiu19940211@163.com
Key Words Non-steroidal anti-inflammatory drugs; Juvenile idiopathic arthritis; Network meta-analysis; Systematic review
Core Tip In summary, celecoxib (6 mg/kg bid) was found to be the most effective non-steroidal anti-inflammatory drug for treating juvenile idiopathic arthritis. Rofecoxib, piroxicam, and meloxicam may be safer options, but further research is needed to confirm these findings in larger trials with higher quality studies.
Publish Date 2024-04-16 07:57
Citation Zeng T, Ye JZ, Qin H, Xu QQ. Systematic review and network meta-analysis of different non-steroidal anti-inflammatory drugs for juvenile idiopathic arthritis. World J Clin Cases 2024; 12(12): 2056-2064
URL https://www.wjgnet.com/2307-8960/full/v12/i12/2056.htm
DOI https://dx.doi.org/10.12998/wjcc.v12.i12.2056
Full Article (PDF) WJCC-12-2056-with-cover.pdf